Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pogejiuxin Decoction for HFpEF
NCT06629246Completed
- Sponsor
- Chongqing Traditional Chinese Medicine Hospital
- Start
- Sep 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pogejiuxin decoction in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by Chongqing Traditional Chinese Medicine Hospital. Primary endpoints: N-terminal pro-brain natriuretic peptide at 7 days, Left Ventricular Ejection Fraction at 7 days and 7 more. Started Sep 2021; status: completed.
02
Drugs
pogejiuxin decoction
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT06629246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06629246.